|
|
|
Volumn 2 Suppl 2, Issue , 2004, Pages
|
|
Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
PACLITAXEL;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG COMBINATION;
FEMALE;
HUMAN;
OVARY TUMOR;
REVIEW;
STATISTICS;
TREATMENT FAILURE;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARBOPLATIN;
CISPLATIN;
CLINICAL TRIALS AS TOPIC;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
OVARIAN NEOPLASMS;
PACLITAXEL;
TREATMENT FAILURE;
|
|
EID: 33645612099
PISSN: 15401405
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (52)
|
